EA can inhibit neuronal ferroptosis after cerebral ischemia/reperfusion and attenuate cerebral ischemia/reperfusion injury by decreasing the content of GSH and ROS and downregulating the expression of GPX4. Here, GPX4 is linked to Cerebral ischemia.